UAE reports 430 new coronavirus cases and one death
25 Jun 2020
Doctors read a document of a patient. File AFP
Gulf Today, Staff Reporter
The UAE Health Ministry conducted 49,000 Covid-19 tests, and revealed 430 new cases and one death.
This brings the total number of cases to 46,563. The new cases identified are undergoing treatment.
A doctor checks a blood sample of a patient. File/ AFP
The total number of recovered cases of coronavirus has reached 35,165.
The ministry said 760 cases recovered on Thursday after receiving treatment.
The person who died was suffering from other illness. The total number of deaths in the country reached 308.
On the hand, the Abu Dhabi Stem Cell Centre (ADSCC) has now treated more than 2000 patients suffering from COVID-19, with 1200 already fully recovered from the effects of the virus.
ADSCC announced today that it had succeeded in ramping up the number of treatments from the 73 in the initial clinical trial. The large increase was as a result of a major effort by staff at the centre to treat as many people as possible following the UAE Government’s decision to make it available free of charge to all moderate-to-high risk COVID-19 patients in the country.
The Government’s decision came after the treatment, branded UAECell19, demonstrated efficacy and an impressive safety profile reflected in the absence of significant changes in adverse events reported, an absence of any unexpected serious reactions (such as anaphylaxis, allergic reactions or sudden death) and an absence of any lung complications as determined by radiological exams from inhalation of the nebulized product.
A team of doctors and researchers at ADSCC, led by Dr Yendry Ventura, announced in May they had developed a new treatment for COVID-19 patients. UAECell19, an autologous stem cells based therapy, appears to help the body fight the virus and makes the disease less harmful.
Following an initial trial, researchers were able to conclude that UAECell19 reduced the duration of hospitalization from 22 days to just six, when compared to patients who had received standard treatment.